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Abstract 
Standard ortho-k lenses have a treatment zone (area of corneal flattening) of 5.0mm in diameter. If the 
pupil dilates to more than 5.0mm, at night for example, the result is glare. Currently, standard ortho-k 
lenses have an optical zone of 6.0mm, leading to a 5.0mm treatment zone. In our experiment, we 
attempted to increase the treatment zone to 6.0m by using ortho-k lenses with a 7.0mm optical zone. 
Increasing the treatment zone would not only significantly reduce complaints of night-time glare, but it 
would put us on par with corrective laser surgery, which also has a 6.0mrn treatment zone. This would 
ultimately make orthokeratology a more viable option to a larger segment of the population. Originally 16 
subjects were used for the experiment. The 1 half of the experiment consisted of fitting the students with 
standard 5.Om treatment zone ortho-k lenses. This trial period allows for lens parameter changes to 
achieve the optimum fit. The second trial consisting of the larger treatment zone has not been reached as 
of right now. The initial standard fits are being refined to custom fits for many patients. There have also 
been significant complications in terms of allergic reactions, undercorrection/overcorrection, non-
compliance and high patient discomfort. The study has yet to be completed and therefore any results 
regarding the treatment zone expansion are inconclusive. The study will be completed within 1 year of 
this paper's release date and definitive conclusions will be made at that time. 
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Abstract 
Standard ortho-k lenses have a treatment zone (area of corneal flattening) of 
5.0mm in diameter. If the pupil dilates to more than 5.0mm, at night for example, the 
result is glare. Currently, standard ortho-k lenses have an optical zone of 6.0mm, leading 
to a 5.0mm treatment zone. In our experiment, we attempted to increase the treatment 
zone to 6 . 0 m  by using ortho-k lenses with a 7.0mm optical zone. Increasing the 
treatment zone would not only significantly reduce complaints of night-time glare, but it 
would put us on par with corrective laser surgery, which also has a 6.0mrn treatment 
zone. This would ultimately make orthokeratology a more viable option to a larger 
segment of the population. Originally 16 subjects were used for the experiment. The 1 
half of the experiment consisted of fitting the students with standard 5 . O m  treatment 
zone ortho-k lenses. This trial period allows for lens parameter changes to achieve the 
optimum fit. The second trial consisting of the larger treatment zone has not been 
reached as of right now. The initial standard fits are being refined to custom fits for 
many patients. There have also been significant complications in terms of allergic 
reactions, undercorrection/overcorrection, non-compliance and high patient discomfort. 
The study has yet to be completed and therefore any results regarding the treatment zone 
expansion are inconclusive. The study will be completed within 1 year of this paper's 
release date and definitive conclusions will be made at that time. 
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Introduction 
Orthokeratology has been a very viable option for many patients who are cautious 
with there eyes and do not want to have lasik preformed for vision correction. The 
orthokeratology procedure has been around for many decades and recently has undergone 
vast improvements in the lens design to significantly increase the success rate of the 
lenses. Modern ortho-k lenses are healthier in that there allow for more gas exchange. 
The lenses have also changed in shape. The lenses have multiple curvatures to allow for 
maximal centration of fit and maximum efficiency of vision correction. In relation to 
lasik the advantage of ortho-k lies in the fact that it isn't an invasive procedure. Ortho-k 
involves gas permeable lenses that sit on your eye while you sleep. These lenses reshape 
the cornea resulting in a desirable change in refractive error. The results of these lenses 
are also reversible and therefore any undesired changes in prescriptions can be 
compensated for. 
Over the many years both ortho-k and lasik have been performed there have been 
significant number of cases of unwanted vision changes. The most notable side effects 
have been night vision concerns with patients displaying symptoms of halos and glare. 
These symptoms seem to rise due to a direct result of pupil expansion from lack of light 
causing peripheral light rays that are normally blocked to enter the eye. These peripheral 
beams of light are passing through untreated corneal area therefore focused at a different 
retinal point than the central rays that pass through the treated corneal area. In attempt to 
decrease the amount of halos and glare lasik has used a large treatment zone which is 
lmrn larger than the standard ortho-k lens design. Also in order to further decrease 
patient symptoms a new technology has been introduced for lasik. Wavefront technology 
which allows for a more accurate custom removal of sections of the stroma provides even 
a better spherical surface on the cornea resulting in fewer symptoms of glare or halos. 
The goal of this study is to attempt to keep ortho-k at par with lasik by increasing 
the original corneal treatment zone of 5mm to 6mm (equivalent to lasik treatment zones). 
The lens changes will not eliminate all symptoms of haloslglare but will decrease some of 
issues that subjects with larger pupils present. 
Methods 
The study initially began with 25 possible candidates for the study with age 
ranges from 20-40. Subjects were initially recruited through the use of a sign up sheet. 
Subjects had to meet a certain criteria entailing; myopic range of -0.75 D to -4.00 D 
and/or up to 1 .OO D of astigmatism. Potential subjects were put through a comprehensive 
visual examination. The examination allowed for us to selectively remove candidates 
that did not meet the above criteria and provided a more accurate distance prescription. 
The Case History screened for any systemic/ocular conditions that could complicate.*. 
candidate's vision. Ocular health exam portion determined if any candidate display& 
any ongoing infection or had any corneal complication that could inhibit the candidate 
fiom wearing the ortho-k lenses. The exams gave us a final number of 16 subjects. 
These subjects were asked to fill out a consent form informing the subjects of common 
potential risks associated with any and all contact lenses, trial outline consisting of wear 
schedule. Subjects were informed the study consisted of two trials of a month each with 
2 different lenses but were given no information regarding lens names or of the change of 
treatment zone size increase from 5rnrn in the 1" trial to 6rnm in the 2nd trial. 
Each subject was required to fill out a questionnaire at three points of the study: 
lSt exam before any lens is inserted, end of the lst trial and end of 2nd trial. The 
questionnaire gave the subjective feedback regarding halos around light. Subjects were 
asked about halos around light in different settings and also the difference in halos when 
wearing corrective spectacles vs. contact lenses. 
BE ortho-k lenses were used for the study. The selection of lens parameters was 
determined by the WID,  topography fiom the Medrnont and manifest refraction. This 
data is inserted into the BE computer program and the program calculates an initial trial 
lens for the subject. The trial lenses were dispensed and each subject received patient 
education on removal and insertion. Each subject received Optimum Care system and 
was educated regarding cleaning procedures. One day morning follow up was scheduled 
with specific instructions of wearing the lenses to visit. The follow up consisted of visual 
acuities, topography, over refraction and slit lamp evaluation to assess the position and fit 
of lenses. The BE computer program compares the topographies and evaluates the 
prescription change to give the final lenses for the trial. The final lenses are the same pair 
or another more accurate lens pair is calculated out. In the later case a 1 day follow up is 
again rescheduled to reassess the new pair of lenses. After the final fit is determined and 
the 1 day follow up is successful a 1 week follow up, and 4 week follow up is performed. 
At the end of the 4 weeks the lens is changed to the larger 6mrn treatment zone lens. 
marks the end of the 1" trial and the beginning of the 2nd trial. The same protocol is us&. 
for this trial as the last. Subjects at the end of the trial return the lenses and receive no 
compensation other than a retainer lens which maintains corrective efforts of the BE 
ortho-k lenses. 
Results 
Currently the lSt rial is underway and not completed. The BE system required 
multiple custom fits for the subjects and therefore time delays occurred. Also the BE 
compmy is based in Canada the lenses have to pass through U.S. Customs. The FDA has 
to approve lenses in order for them to enter the country. These delays took away the 
window of opportunity to do a complete consecutive 2 month trial study. Complications 
of the study resulted in the loss or dismissal of 4 subjects. One subject relocated and 
could not reach the clinic for the trials and therefore discontinued. Two subjects had too 
much lens discomfort on the 1" follow up with one subject showing significant signs of 
punctate keratitis. These subjects removed themselves from the study. One subject was 
removed from study due to papules forming on the lid conjunctiva indicating an allergic 
reaction. Other complications of the study include non-compliance by patients in terms 
of wearing schedule. Multiple patients have lost or damaged a lens therefore requiring 
the shipping of new ones. The remaining subjects have shown significant improvements 
in VA's and final custom lenses have been ordered for many these subjects. Subjective 
responses from patients are positive in terms of lifestyle changes however the trial is in 
the preliminary stages therefore no feedback in terms of night vision and halos has been 
collected. 
Discussion 
Complications of this study have resulted in delays that were unexpected. The 
patients that remain with the study have shown great motivation and patience. The study 
is being continued by our fellow colleagues and will be completed in the near future. The 
final analysis of this study has yet to be completed therefore any conclusions at this time 
would be invalid. 
